Indication
Adult Stem Cells
2 clinical trials
3 products
Clinical trial
The Safety Study of Stemchymal® (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I TrialStatus: Withdrawn, Estimated PCD: 2020-05-18
Product
Stemchymal®Clinical trial
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response SyndromeStatus: Recruiting, Estimated PCD: 2025-12-01
Product
MultiStemProduct
Placebo